CompanyGraph
What stands out
- Most companies in its industry are production businesses; this one is a sense-making business
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- ScaleMarket cap is $6.62B, above the global median of $1.18B
- FinancialsAltman Z-Score 7.49: safe zone
- Interpretations1 currently firing — 1
What this company is and how it runs — written from structure, not news.
What stands out
- Most companies in its industry are production businesses; this one is a sense-making business
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.24%Below 5Y avg (0.67%)
Annual Rate
CNY 0.13Paid annual
Payout Ratio
33.0%Sustainable
Last Ex-Dividend
Jul 10, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
44.58BCNY6.62B · vs all stocks (USD)
Trailing P/E
59.29xvs Diagnostics & Research peers
Revenue (TTM)
7.07BCNY1.05B · vs all stocks (USD)
Profit Margin
10.91%vs Diagnostics & Research peers
Beta
0.3400xvs all stocks
52-Week Change
-22.37%vs all stocks
Market Capitalization
44.58BCNY6.62B · vs all stocks (USD)
Enterprise Value
50.36BCNY7.48B · vs all stocks (USD)
Trailing P/E
59.29xvs Diagnostics & Research peers
Forward P/E
42.96xvs Diagnostics & Research peers
Price to Sales (TTM)
6.57xvs Diagnostics & Research peers
Price to Book (MRQ)
2.21xvs Diagnostics & Research peers
Enterprise to Revenue
7.12xvs Diagnostics & Research peers
Enterprise to EBITDA
61.10xvs Diagnostics & Research peers
Gross Margin
26.64%vs Diagnostics & Research peers
Profit Margin
10.91%vs Diagnostics & Research peers
Operating Margin
9.90%vs Diagnostics & Research peers
Return on Assets (TTM)
1.33%vs Diagnostics & Research peers
Return on Equity (TTM)
4.23%vs Diagnostics & Research peers
Revenue (TTM)
7.07BCNY1.05B · vs all stocks (USD)
Revenue per Share (TTM)
8.39CNYUpdated Aug 19, 2026Quarterly Revenue Growth
15.20%vs Diagnostics & Research peers
Gross Profit (TTM)
1.88BCNY279.71M · vs all stocks (USD)
EBITDA (TTM)
1.44BCNY213.26M · vs all stocks (USD)
Net Income (TTM)
771.46MCNY114.58M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-70.40%vs Diagnostics & Research peers
Operating Cash Flow (TTM)
1.24BCNY183.85M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
1.03BCNY153.47M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.1260CNYUpdated Aug 19, 2026Trailing Annual Dividend Yield
0.24%vs all stocks
5-Year Average Dividend Yield
0.67%vs all stocks
Payout Ratio
32.97%vs Diagnostics & Research peers
Minority Interest (Equity)
3.30BCNYFY2025 · Dec 31, 2025Revenue
6.83BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
4.96BCNYFY2025 · Dec 31, 2025Gross Profit
1.87BCNYFY2025 · Dec 31, 2025Operating Income
666.64MCNY99.01M · vs all stocks (USD)
Pre-tax Income
1.00BCNYFY2025 · Dec 31, 2025Income Tax Expense
198.16MCNYFY2025 · Dec 31, 2025Net Income
805.06MCNYFY2025 · Dec 31, 2025EBIT
1.09BCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
1.41BCNYFY2025 · Dec 31, 2025Research & Development
257.64MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
322.20MCNYFY2025 · Dec 31, 2025Other Operating Expenses
34.93MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
15.13MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
90.56MCNYFY2025 · Dec 31, 2025EPS (Basic)
1.04CNYFY2025 · Dec 31, 2025EPS (Diluted)
1.04CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
853.74MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
853.74MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
805.06MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
82.83MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
697.84MCNYFY2025 · Dec 31, 2025Free Cash Flow
489.40MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.72BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
805.06MCNYFY2025 · Dec 31, 2025Other Non-cash Items
150.32MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-199.80MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-57.73MCNYFY2025 · Dec 31, 2025Capital Expenditures
-208.44MCNYFY2025 · Dec 31, 2025Net Acquisitions
-164.95MCNYFY2025 · Dec 31, 2025Purchase of Investments
-1.92BCNYFY2025 · Dec 31, 2025Sale of Investments
2.83BCNYFY2025 · Dec 31, 2025Other Investing Activity
-49.19MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
491.56MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
1.14BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-2.37BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-343.66MCNYFY2025 · Dec 31, 2025Other Financing Charges
-347.19MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-1.93BCNYFY2025 · Dec 31, 2025Shares Outstanding
861.03MSharesUpdated Aug 19, 2026Float Shares
611.02MSharesUpdated Aug 19, 2026% Held by Insiders
32.29%vs all stocks
% Held by Institutions
27.26%vs all stocks
Total Cash (MRQ)
2.20BCNY326.87M · vs all stocks (USD)
Total Cash per Share (MRQ)
2.57CNYUpdated Aug 19, 2026Total Debt (MRQ)
1.72BCNY255.65M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0701xvs Diagnostics & Research peers
Current Ratio (MRQ)
2.30xvs Diagnostics & Research peers
Book Value per Share (MRQ)
24.46CNYUpdated Aug 19, 2026Total Assets
28.36BCNY4.21B · vs all stocks (USD)
Total Current Assets
6.18BCNYFY2025 · Dec 31, 2025Total Liabilities
4.10BCNYFY2025 · Dec 31, 2025Total Non-current Assets
22.18BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
1.27BCNYFY2025 · Dec 31, 2025Total Current Liabilities
2.84BCNYFY2025 · Dec 31, 2025Cash
1.71BCNYFY2025 · Dec 31, 2025Cash Equivalents
67.91MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.78BCNYFY2025 · Dec 31, 2025Other Short-term Investments
59.46MCNYFY2025 · Dec 31, 2025Accounts Receivable
1.41BCNYFY2025 · Dec 31, 2025Inventory
41.50MCNYFY2025 · Dec 31, 2025Accounts Payable
371.12MCNYFY2025 · Dec 31, 2025Short-term Debt
712.55MCNYFY2025 · Dec 31, 2025Other Current Liabilities
38.79MCNYFY2025 · Dec 31, 2025Long-term Debt
963.65MCNYFY2025 · Dec 31, 2025Common Stock (Book)
861.03MCNYFY2025 · Dec 31, 2025Retained Earnings
9.32BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
24.26BCNY3.60B · vs all stocks (USD)
Treasury Stock
300.07MCNYFY2025 · Dec 31, 202552-Week Low
35.57CNYUpdated Aug 19, 202652-Week High
68.87CNYUpdated Aug 19, 202652-Week Change
-22.37%vs all stocks
Beta
0.3400xvs all stocks
50-Day MA
47.14CNYUpdated Aug 19, 2026200-Day MA
52.75CNYUpdated Aug 19, 2026Avg 10-Day Volume
24.24MSharesUpdated Aug 19, 2026Avg 30-Day Volume
24.14MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
0.9100CNYUpdated Aug 19, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Working Capital Pattern
What customers owe has grown three years running, while it clears stock quickly and pays suppliers quickly.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Most companies in its industry are production businesses; this one is a sense-making businessSignificant
Industry peers: 70.00Share on the common pattern %: 97.00
Financial Health
Altman Z-Score 7.49: safe zoneNotable
Altman Z-Score: 7.49
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Scale
Market cap is $6.62B, above the global median of $1.18BNotable
Market cap (USD): 6,621,605,115.624Global Median: 1,179,398,897.704
Revenue is $1.05B, above the global median of $534.05MNotable
Revenue (USD): 1,050,055,809.782Global Median: 534,052,387.958
Levered free cash flow is $153.47M, above the global median of $19.23MNotable
Levered free cash flow (USD): 153,466,138.985Global Median: 19,234,564.734
Companies that share the same coordination system — how they create, deliver, or capture value.
Primarius Technologies Co. Ltd.
Tier 1SenseMakingThroughput-Bound ConversionProductionInterface
Medpace Holdings Inc.
Tier 1SenseMakingThroughput-Bound ConversionFlowRule
Merit Interactive Co., Ltd.
Tier 1SenseMakingThroughput-Bound ConversionInterfaceProduction
Chengdu Yunda Technology Co. Ltd.
Tier 1SenseMakingThroughput-Bound ConversionInterfaceFlow
JC Finance & Tax Interconnect Co. Ltd.
Tier 1SenseMakingThroughput-Bound ConversionFlowRule
Digital China Holdings Limited
Tier 1SenseMakingThroughput-Bound ConversionInterfaceProduction
Materials Analysis Technology Inc.
Tier 1SenseMakingThroughput-Bound ConversionProductionRule
Wuhan Kotei Informatics Co., Ltd.
Tier 1SenseMakingThroughput-Bound ConversionProductionFlow
Great Chinasoft Technology Co., Ltd.
Tier 1SenseMakingThroughput-Bound ConversionInterfaceFlow
Epigral Ltd.
Tier 1SenseMakingThroughput-Bound ConversionProductionRisk
Companies that share active interpretations — structural patterns currently present in both stocks.
Chipotle Mexican Grill, Inc.
1 interpretationWorking Capital Pattern
Paycom Software, Inc.
1 interpretationWorking Capital Pattern